143 related articles for article (PubMed ID: 3123372)
1. Comparison of the role of complement in immunity to Schistosoma mansoni in rats and mice.
Vignali DA; Bickle QD; Taylor MG; Tennent G; Pepys MB
Immunology; 1988 Jan; 63(1):55-61. PubMed ID: 3123372
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni. Reduction of irradiated cercariae-induced resistance.
Kelly EA; Colley DG
J Immunol; 1988 Apr; 140(8):2737-45. PubMed ID: 3128606
[TBL] [Abstract][Full Text] [Related]
3. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
4. Role of cellular and humoral immunity and helper cell involvement in permissiveness to infection by Schistosoma mansoni.
Mendlovic F; Tarrab-Hazdai R; Arnon R
Eur J Immunol; 1987 Aug; 17(8):1151-7. PubMed ID: 2957216
[TBL] [Abstract][Full Text] [Related]
5. Passive transfer with serum and IgG antibodies of irradiated cercaria-induced resistance against Schistosoma mansoni in mice.
Mangold BL; Dean DA
J Immunol; 1986 Apr; 136(7):2644-8. PubMed ID: 3081647
[TBL] [Abstract][Full Text] [Related]
6. A role for CD4+ but not CD8+ T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections.
Vignali DA; Crocker P; Bickle QD; Cobbold S; Waldmann H; Taylor MG
Immunology; 1989 Aug; 67(4):466-72. PubMed ID: 2570035
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes, or complement.
Sher A; Hieny S; James SL; Asofsky R
J Immunol; 1982 Apr; 128(4):1880-4. PubMed ID: 6801124
[TBL] [Abstract][Full Text] [Related]
8. IgE antibody and resistance to infection. II. Effect of IgE suppression on the early and late skin reaction and resistance of rats to Schistosoma mansoni infection.
Kigoni EP; Elsas PP; Lenzi HL; Dessein AJ
Eur J Immunol; 1986 Jun; 16(6):589-95. PubMed ID: 3087755
[TBL] [Abstract][Full Text] [Related]
9. ICAM-1 and iNOS expression increased in the skin of mice after vaccination with gamma-irradiated cercariae of Schistosoma mansoni.
Ramaswamy K; He YX; Salafsky B
Exp Parasitol; 1997 Jun; 86(2):118-32. PubMed ID: 9207742
[TBL] [Abstract][Full Text] [Related]
10. Schistosoma mansoni: protective immunity in IL-4-deficient mice.
King CL; Malhotra I; Jia X
Exp Parasitol; 1996 Nov; 84(2):245-52. PubMed ID: 8932774
[TBL] [Abstract][Full Text] [Related]
11. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite.
Wynn TA; Reynolds A; James S; Cheever AW; Caspar P; Hieny S; Jankovic D; Strand M; Sher A
J Immunol; 1996 Nov; 157(9):4068-78. PubMed ID: 8892641
[TBL] [Abstract][Full Text] [Related]
12. In vivo T cell depletion regulates resistance and morbidity in murine schistosomiasis.
Phillips SM; Linette GP; Doughty BL; Byram JE; Von Lichtenberg F
J Immunol; 1987 Aug; 139(3):919-26. PubMed ID: 2885376
[TBL] [Abstract][Full Text] [Related]
13. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni.
King CL; Xianli J; Malhotra I; Liu S; Mahmoud AA; Oettgen HC
J Immunol; 1997 Jan; 158(1):294-300. PubMed ID: 8977202
[TBL] [Abstract][Full Text] [Related]
14. The role of complement in innate, adaptive and eosinophil-dependent immunity to the nematode Nippostrongylus brasiliensis.
Giacomin PR; Gordon DL; Botto M; Daha MR; Sanderson SD; Taylor SM; Dent LA
Mol Immunol; 2008 Jan; 45(2):446-55. PubMed ID: 17675237
[TBL] [Abstract][Full Text] [Related]
15. Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.
James SL; Pearce EJ; Sher A
J Immunol; 1985 May; 134(5):3432-8. PubMed ID: 3980998
[TBL] [Abstract][Full Text] [Related]
16. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms.
Jankovic D; Wynn TA; Kullberg MC; Hieny S; Caspar P; James S; Cheever AW; Sher A
J Immunol; 1999 Jan; 162(1):345-51. PubMed ID: 9886405
[TBL] [Abstract][Full Text] [Related]
17. Features of Schistosoma mansoni infection in SCID mice.
Ozaki T; Kumagai M; Inaba T; Soto H; Ito M; Kamiya H
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):838-43. PubMed ID: 9656412
[TBL] [Abstract][Full Text] [Related]
18. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
Hoffmann KF; James SL; Cheever AW; Wynn TA
J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689
[TBL] [Abstract][Full Text] [Related]
19. Intraspecific cross-protection in mice immunized with irradiated Schistosoma mansoni cercariae.
Lewis FA; Winestock J; Dingaan B; Richards C; Dean DA
J Parasitol; 1987 Aug; 73(4):787-91. PubMed ID: 3114466
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity to Schistosoma mansoni in mice is dependent on antibody and complement but not on radiosensitive leukocytes.
Goes AM; Ramalho-Pinto FJ
Immunol Lett; 1991 Apr; 28(1):57-63. PubMed ID: 1906428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
